Unicycive Therapeutics (UNCY) Inventory (2024 - 2026)

Unicycive Therapeutics (UNCY) has 3 years of Inventory data on file, last reported at $7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory changed N/A year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (changed N/A YoY), and the FY2025 full-year result was $6.2 million, up 71.73% from the prior year.
• Inventory for Q1 2026 stood at $7.7 million, up from $6.2 million in the prior quarter.
• Across five years, Inventory topped out at $7.7 million in Q1 2026 and bottomed at $3.6 million in Q4 2024.
• The 3-year median for Inventory is $6.2 million (2025), against an average of $5.8 million.
• Peak annual rise in Inventory reached 71.73% in 2025, while the deepest fall reached 71.73% in 2025.
• A 3-year view of Inventory shows it stood at $3.6 million in 2024, then jumped by 71.73% to $6.2 million in 2025, then climbed by 24.24% to $7.7 million in 2026.
• The last three Inventory figures came in at $7.7 million (Q1 2026), $6.2 million (Q4 2025), and $3.6 million (Q4 2024), per Business Quant data.

Peer Comparison